| Q35534993 | A national validation study of the acute-toxic-class method--an alternative to the LD50 test |
| Q28544909 | A polymeric prodrug of 5-fluorouracil-1-acetic acid using a multi-hydroxyl polyethylene glycol derivative as the drug carrier |
| Q78640601 | A valuation of hydrocortisone ointment |
| Q47443778 | Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption |
| Q54629111 | An alternative method of large scale plasma fractionation for the lsolation of serum albumin |
| Q76848982 | BEHAVIOR OF THE TYMPANIC MUCOSA TOWARD VARIOUS DRUGS USED IN OTOSURGERY. EXPERIMENTAL ANIMAL STUDIES |
| Q36604222 | Benzocaine Diffusion from Polyethylene Glycol through Human Stratum Corneum |
| Q35876520 | Bowel preparation for gastrointestinal procedures |
| Q43700006 | Clinical Investigation of Intermediate- and High-Purity Antihaemophilic Factor (Factor VIII) Concentrates |
| Q67515762 | Disposition of diethylstilbestrol in the rhesus monkey |
| Q39649284 | Efficacy and Toxicity of the Solvent Polyethylene Glycol 400 in Monkey Model |
| Q55924384 | Ethylene Glycol |
| Q28484458 | Evaluation of 14 organic solvents and carriers for screening applications in zebrafish embryos and larvae |
| Q69761423 | Experimental induction of uterine cancer in rats by N-ethyl-N'-nitro-N-nitrosoguanidine dissolved in polyethylene glycol |
| Q23917717 | Federal government regulation of occupational skin exposure in the USA |
| Q59747089 | Golytely™ solution for colonoscopy preparation |
| Q83260283 | Nonosmotic Effects of Polyethylene Glycols upon Sodium Transport and Sodium-Potassium Selectivity by Rice Roots |
| Q44538769 | Novel poly(ethylene glycol) derivatives with carboxylic acid pendant groups: synthesis and their protection and enhancing effect on non-viral gene transfection systems. |
| Q39641048 | Polyethylene glycol 400: Solvent and anticonvulsant? |
| Q67857325 | Polymeric gastrointestinal MR contrast agents |
| Q44755804 | Polymeric sustained local drug delivery system for the prevention of vascular intimal hyperplasia |
| Q71755814 | Response of dogs to repeated intravenous injection of polyethylene glycol 4000 with notes on excretion and sensitization |
| Q35978436 | Safety issues regarding colonic cleansing for diagnostic and surgical procedures |
| Q36533097 | Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates |
| Q40115681 | Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential |
| Q37415968 | Surface engineering of liposomes for stealth behavior |
| Q39769945 | The Biodegradation of Polyethylene Glycols |
| Q75823724 | The chemical manipulation of food |
| Q67781108 | The effect of delta 9-tetrahydrocannabinol and LSD on the acquisition of an active avoidance response in the rat |
| Q69794776 | Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems |
| Q70501178 | [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer |